John D Diekman's Net Worth
Estimate Recalculated Feb 28, 2025 11:55PM EST
Who is John D Diekman
John D Diekman has an estimated net worth of $2.42 Million. This is based on reported shares across multiple companies, which include Skye Bioscience, Inc., Zai Lab Ltd, Crinetics Pharmaceuticals, Inc., Pear Therapeutics, Inc., IDEAYA Biosciences, Inc., ARVINAS INC., Cidara Therapeutics, Inc., VIVEVE MEDICAL, INC., scPharmaceuticals Inc., Homology Medicines, Inc., Aprea Therapeutics, Inc., Audentes Therapeutics, Inc., PHASERX, INC., EPIRUS Biopharmaceuticals, Inc., and AFFYMETRIX INC.
SEC CIK
John D Diekman's CIK is 0001240357
Past Insider Trading and Trends
2005 was John D Diekman's most active year for acquiring shares with 4 total transactions. John D Diekman's most active month to acquire stocks was the month of May. 2005 was John D Diekman's most active year for disposing of shares, totalling 6 transactions. John D Diekman's most active month to dispose stocks was the month of April. 2007 saw John D Diekman paying a total of $542,482.25 for 48,299 shares, this is the most they've acquired in one year. In 2021 John D Diekman cashed out on 3,000 shares for a total of $394,770.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
